Kezar Life Sciences, Inc. (KZR) Interest & Investment Income (2018 - 2026)

Kezar Life Sciences has reported Interest & Investment Income for 7 years, with the latest figure at $609000.0 in Q1 2026.

• Quarterly Interest & Investment Income fell 57.11% year-over-year to $609000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (down 51.1% YoY) and the FY2025 annual result came in at $4.4 million, down 47.48% from the prior year.
• Interest & Investment Income retreated to $609000.0 in Q1 2026 per KZR's latest filing, from $801000.0 in the prior quarter.
• Over five years, Interest & Investment Income peaked at $2.5 million in Q1 2024 and troughed at $609000.0 in Q1 2026.
• A 3-year average of $1.5 million and a median of $1.4 million in 2025 frame the typical range for Interest & Investment Income.
• The sharpest annual moves came in 2025 and 2026: Interest & Investment Income plunged 42.11% in 2025, then sank 57.11% in 2026.
• Over 3 years, Interest & Investment Income stood at $1.7 million in 2024, then plunged by 53.81% to $801000.0 in 2025, then retreated by 23.97% to $609000.0 in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $609000.0, $801000.0, and $1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.